Pfizer

The quadruple-vaccinated CEO of Pfizer, Albert Bourla, tested positive for COVID-19 and is experiencing very mild symptoms.

Pfizer's CEO Albert Bourla announced last week that he is donating his $1 million Genesis Prize towards establishing a holocaust museum in Thessaloniki, Greece. Dr. Bourla, 60, said he was donating the entire sum to the museum in his native...

How does ouzo, the anise-flavored aperitif that is widely consumed in Greece and Cyprus, relate to Albert Bourla?

The Food and Drug Administration on Tuesday authorized a second booster of Pfizer-BioNTech and Moderna for adults 50 years and older, announcing that a fourth shot improves protection against severe Covid-19. The agency also authorized a second Pfizer-BioNTech booster for...

Greece marked an impressive increase of 74.3 percent in foreign direct investment (FDI) in 2021, according to Enterprise Greece

Pfizer, the international pharmaceuticals giant helmed by Thessaloniki-born Dr. Albert Bourla, made a staggering $36.8 billion on its first-in-the-world coronavirus vaccine last year. First authorized for emergency use in December of 2020, just nine months after the virus began to...

The Pfizer corporation, the first pharmaceutical firm to have a vaccine against the coronavirus, is expected to ask the United States Food and Drug Administration to authorize its inoculation for children under the age of 5. At a time when...

Pfizer CEO Albert Bourla on Saturday said people getting COVID-19 booster shots every four to five months is "not a good scenario" and argued that an annual vaccine would be a better approach to fighting the virus. Bourla told the...

A fourth shot will be needed as the power of the booster wanes, Moderna CEO Stephane Bancel stated on Thursday while addressing a Goldman Sachs healthcare conference. His comments were the first such definitive statement by Moderna regarding the need...

Pfizer and BioNTech announced on Wednesday that they will work together to develop an MRNA vaccine for the viral infection called shingles. The pharmaceutical companies worked together to create the world's first fully-approved MRNA vaccine for the coronavirus in 2020. They...